Gland Pharma Ltd Quarterly Results

Gross Sales

1,424.91

1,384.05

1,405.83

1,401.71

1,537.45

Excise Duty

0

0

0

0

0

Net Sales

1,424.91

1,384.05

1,405.83

1,401.71

1,537.45

Other Operating Income

0

0

0

0

0

Other Income

44.03

58.49

59.66

51.43

42.15

Total Income

1,468.94

1,442.55

1,465.49

1,453.14

1,579.6

Total Expenditure

1,077.39

1,024.1

1,108.78

1,137.31

1,178.8

PBIDT

391.54

418.45

356.72

315.82

400.8

Interest

7.45

22.82

6.11

5.62

9.96

PBDT

384.09

395.63

350.6

310.21

390.84

Depreciation

95.76

96.33

93.83

91.96

92.61

Minority Interest Before NP

0

0

0

0

0

Tax

103.74

94.54

95.9

77.79

100.17

Deferred Tax

-1.95

0.07

-2.66

-3.31

5.64

Reported Profit After Tax

186.54

204.69

163.53

143.76

192.42

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

186.54

204.69

163.53

143.76

192.42

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

186.54

204.69

163.53

143.76

192.42

EPS (Unit Curr.)

11.32

12.42

9.93

8.73

11.68

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.48

16.48

16.48

16.48

16.47

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

27.47

30.23

25.37

22.53

26.06

PBDTM(%)

26.95

28.58

24.93

22.13

25.42

PATM(%)

13.09

14.78

11.63

10.25

12.51